Tremfya (guselkumab)

pCPA File Number: 21013
Negotiation Status:
Concluded without agreement
Indication(s):
Psoriasis, moderate to severe plaque
Sponsor/Manufacturer:
Janssen Inc.
CADTH Project Number:
SR0530-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: